Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study
- PMID: 2984345
- DOI: 10.1200/JCO.1985.3.4.521
Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study
Abstract
Multivariate statistical methods were used to study prognosis for 632 patients entered on the second National Wilms' Tumor Study who had nonmetastatic, unilateral disease at diagnosis. Separate analyses were conducted for each of four endpoints: abdominal recurrence, distant metastasis, relapse without regard to site, and death. The two most important predictors for metastasis and general relapse were an unfavorable (anaplastic or sarcomatous) histology and the presence of microscopically confirmed disease in the regional lymph nodes. Operative spillage of tumor increased the rates of abdominal recurrence and death, even after accounting for histology and lymph node effects. The presence of a tumor thrombus in the renal vein or IVC increased the risk of metastasis, and intrarenal vascular invasion was associated with general relapse after accounting for histology, lymph nodes, and spillage. However, these latter associations were weaker, and some uncertainty remains regarding the true prognostic import of such findings due to a high degree of collinearity among variables. By contrast to the results of a similar data analysis for the first National Wilms' Tumor Study, specimen weight had no bearing on outcome, and the effects of age at diagnosis were entirely explained by the association of age with other more critical factors.
Similar articles
-
Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study.Cancer. 1978 Apr;41(4):1577-89. doi: 10.1002/1097-0142(197804)41:4<1577::aid-cncr2820410448>3.0.co;2-7. Cancer. 1978. PMID: 205340
-
Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study.Cancer. 1991 Dec 1;68(11):2345-53. doi: 10.1002/1097-0142(19911201)68:11<2345::aid-cncr2820681103>3.0.co;2-t. Cancer. 1991. PMID: 1657352
-
Anaplastic Wilms' tumor: clinical and pathologic studies.J Clin Oncol. 1985 Apr;3(4):513-20. doi: 10.1200/JCO.1985.3.4.513. J Clin Oncol. 1985. PMID: 2984344
-
Wilms' tumor: diagnosis and treatment in the 1990s.Semin Pediatr Surg. 1993 Feb;2(1):59-68. Semin Pediatr Surg. 1993. PMID: 8062023 Review.
-
Current therapy for Wilms' tumor.Oncologist. 2005 Nov-Dec;10(10):815-26. doi: 10.1634/theoncologist.10-10-815. Oncologist. 2005. PMID: 16314292 Review.
Cited by
-
Secondary malignant neoplasms after Wilms tumor: an international collaborative study.Int J Cancer. 2010 Aug 1;127(3):657-66. doi: 10.1002/ijc.25067. Int J Cancer. 2010. PMID: 19950224 Free PMC article.
-
Ureteral extension in Wilms' tumor: a report from the National Wilms' Tumor Study Group (NWTSG).J Pediatr Surg. 2008 Sep;43(9):1625-9. doi: 10.1016/j.jpedsurg.2008.01.067. J Pediatr Surg. 2008. PMID: 18778996 Free PMC article.
-
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.Nat Rev Urol. 2025 Jun 20. doi: 10.1038/s41585-025-01055-1. Online ahead of print. Nat Rev Urol. 2025. PMID: 40542227 Review.
-
Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.J Pediatr Surg. 2012 Apr;47(4):700-6. doi: 10.1016/j.jpedsurg.2011.08.017. J Pediatr Surg. 2012. PMID: 22498384 Free PMC article.
-
Profile and Clinical Outcome of Children with Wilms' Tumor treated at a Tertiary Care Centre, India.South Asian J Cancer. 2022 Mar 22;11(3):260-268. doi: 10.1055/s-0042-1743414. eCollection 2022 Jul. South Asian J Cancer. 2022. PMID: 36588612 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical